Capital Fund Management S.A. Amgen Inc Transaction History

Capital Fund Management S.A.

$33.7 Billion
Q2 2024

A detailed history of Capital Fund Management S.A. transactions in Amgen Inc stock. As of the latest transaction made, Capital Fund Management S.A. holds 14,159 shares of AMGN stock, worth $4.56 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

14,159

Previous 82,587 82.86%

Holding current value

$4.56 Million

Previous $23.5 Million 81.16%

% of portfolio

0.01%

Previous 0.07%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$262.75 - $319.31 $18 Million - $21.8 Million	-68,428 Reduced 82.86%	14,159 $4.42 Million
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $2.25 Million - $2.71 Million	-8,359 Reduced 9.19%	82,587 $23.5 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $23.3 Million - $26.2 Million	90,946 New	90,946 $26.2 Million
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $592,472 - $722,124	2,624 Added 6.37%	43,789 $10.6 Million
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $8.11 Million - $10.3 Million	-35,407 Reduced 46.24%	41,165 $10.8 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $7.81 Million - $8.81 Million	-34,809 Reduced 31.25%	76,572 $17.3 Billion
Q2 2022 Aug 12, 2022	BUY	$230.71 - $256.74 $22 Million - $24.5 Million	95,349 Added 594.74%	111,381 $27.1 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $3.91 Million - $4.58 Million	-18,399 Reduced 53.44%	16,032 $3.41 Million
Q2 2021 Aug 12, 2021	BUY	$233.58 - $259.14 $8.04 Million - $8.92 Million	34,431 New	34,431 $8.39 Million
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $9.42 Million - $11 Million	-42,430 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $7.15 Million - $8.51 Million	-33,036 Reduced 43.78%	42,430 $9.76 Million
Q3 2020 Nov 13, 2020	SELL	$234.65 - $260.95 $16.9 Million - $18.8 Million	-72,129 Reduced 48.87%	75,466 $19.2 Million
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $1.51 Million - $1.85 Million	7,641 Added 5.46%	147,595 $34.8 Million
Q1 2020 May 13, 2020	BUY	$182.24 - $241.7 $17 Million - $22.6 Million	93,394 Added 200.59%	139,954 $28.4 Million
Q4 2019 Feb 13, 2020	SELL	$189.21 - $243.2 $9.16 Million - $11.8 Million	-48,419 Reduced 50.98%	46,560 $11.2 Million
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $66 Million - $79 Million	-378,898 Reduced 79.96%	94,979 $18.4 Million
Q2 2019 Aug 12, 2019	BUY	$166.7 - $195.41 $40.1 Million - $47 Million	240,480 Added 103.03%	473,877 $87.3 Million
Q1 2019 May 13, 2019	BUY	$180.87 - $203.88 $27.2 Million - $30.7 Million	150,346 Added 181.03%	233,397 $44.3 Million
Q4 2018 Feb 13, 2019	BUY	$178.4 - $208.25 $8.1 Million - $9.46 Million	45,427 Added 120.74%	83,051 $16.2 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $1.93 Million - $2.18 Million	-10,428 Reduced 21.7%	37,624 $7.8 Million
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $961,927 - $1.08 Million	-5,793 Reduced 10.76%	48,052 $8.87 Million
Q4 2017 Feb 09, 2018	BUY	$168.79 - $188.59 $9.09 Million - $10.2 Million	53,845	53,845 $9.36 Million

Others Institutions Holding AMGN

# of Institutions

3,055

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $172B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.

Account

Capital Fund Management S.A. Amgen Inc Transaction History